Kantar Health Names Richard Martin CEO, Kantar Health Oncology
“Kantar Health has the largest portfolio of oncology data and insight offers in the industry resulting from early recognition by teams that Richard led of the need for comprehensive information in this area,” says Lynnette Cooke, CEO of Kantar Health. “His experience and understanding of client needs and Kantar Health's global competencies will ensure that we continue to advance our service of providing relevant and actionable advice in new product planning, market access and marketing effectiveness in oncology.”
Kantar Health's multidisciplinary oncology team members are located in Europe, North America and Asia. Supported by their scientific, clinical, research and business competencies, the team provides their clients with business decision support on a custom engagement basis and makes available multiclient databases and resources including Oncology Market Access U.S., Oncology Market Access EU, OMT, CancerNFluence and CancerMPact.
“Kantar Health‘s oncology team members are recognized as second to none in their knowledge of this complex disease area, markets and the myriad issues that impact our clients’ efforts to improve treatment,” Mr. Martin says. “It's our mission to collectively marshal the power of our talent, offers and insights globally to help our clients accelerate progress against this terrible disease.”
Mr. Martin has over 30 years of experience in the healthcare industry. He has directly served clients in a wide variety of strategic consulting engagements in the pharmaceutical and biotech industry, including serving as President and COO of MattsonJack, a Kantar Health legacy company.
About Kantar Health (www.kantarhealth.com)
As experts in pharmaceutical and biotechnology consulting and market research, Kantar Health offers unique insights and products that deliver proven results for marketing insights, brand marketing, business development and health economics and outcomes professionals, including:
· The greatest breadth and depth of epidemiology information in the world, spanning patient-reported outcomes and patient care by country, therapy area, specialist--or whatever combination of data you require
· Unmatched experience in the complex oncology market that encompasses business development, clinical management, emerging technologies, marketing and sales, payers and providers, reimbursement and strategic and product planning
· A unique global source of KOLs for multiple therapy areas
Kantar Health's team combines doctorate-level scientific expertise with strong business know-how, ensuring that solutions are both evidence-based and commercially focused. We offer a wide range of expertise in emerging as well as established markets, spanning the product life cycle from product portfolio management to licensing, market access to brand and reputation management, detailing to clinical research, patient outcomes and sales force effectiveness to health and safety. And as part of WPP, the largest marketing agency in the world, Kantar Health can leverage the power of the global group with shared offline and online research methodologies but remain culturally specific and nimble. Kantar Health focuses on getting you the best return.
Website: http://www.kantar.com/expertise/health
Contact
Paula Paradise
Vice President of Global Marketing
Send Email
+1-484-442-1431
This news is a press release provided by Kantar Health. Korea Newswire follows these editorial guidelines.
-
2020년 8월 5일 11:53